You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Influenza Virus Vaccine USP Trivalent Types A and B

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,

Not yet recruiting
  • Influenza, Human
  • Quadrivalent Influenza Vaccine (split virion, inactivated)
  • +2 more
  • (no location specified)
Mar 9, 2023

Influenza Trial in Stamford (CAIV-T)

Completed
  • Influenza
  • CAIV-T
  • Stamford, Connecticut
    Stamford Hospital
Sep 10, 2021

Influenza Trial in Taizhou (Quadrivalent influenza virus subunit vaccine, Quadrivalent split influenza virus vaccine)

Not yet recruiting
  • Influenza
  • Quadrivalent influenza virus subunit vaccine
  • Quadrivalent split influenza virus vaccine
  • Taizhou, Jiangsu, China
    Ab&b Biotechnology Co., Ltd.JS
Jan 12, 2023

Influenza Trial in Heidelburg (CAIV-T)

Completed
  • Influenza
  • CAIV-T
  • Heidelburg, Victoria, Australia
    Austin & Repatriation Medical Centre
Sep 10, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 24, 2022

Plasma Cell Tumor Trial in Atlanta (Pneumococcal 13-valent Conjugate Vaccine, Trivalent Influenza Vaccine)

Active, not recruiting
  • Plasma Cell Neoplasm
  • Pneumococcal 13-valent Conjugate Vaccine
  • Trivalent Influenza Vaccine
  • Atlanta, Georgia
  • +1 more
Jan 24, 2022

Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)

Not yet recruiting
  • Influenza, Human
  • FLU Q-PAN H5N8 Formulation 1
  • +3 more
  • (no location specified)
Jul 27, 2023

Healthy Trial in Tampere (CAIV-T)

Completed
  • Healthy
  • CAIV-T
  • Tampere, Finland
    University of Tampere
Sep 10, 2021

Qualitative, Qualitative, and Functional Studies Over First Year

Completed
  • Astrocytoma
  • +2 more
  • Hepatitis A Vaccine
  • +3 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Oct 28, 2021

Pandemic Influenza Disease Trial in Tampere, München (Placebo (PL), Trivalent influenza virus vaccine (TIV), Adjuvanted

Completed
Has Results
  • Pandemic Influenza Disease
  • Placebo (PL)
  • +3 more
  • Tampere, Finland
  • +1 more
Apr 22, 2021

Influenza Trial in United States (QIV-HD, Licensed TIV-HD1, Investigational TIV-HD2)

Completed
Has Results
  • Influenza
  • QIV-HD
  • +2 more
  • Anaheim, California
  • +35 more
Mar 24, 2022

Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT Lot 1 vaccine (GSK3888550A), RSV MAT Lot 2 vaccine

Completed
  • Respiratory Syncytial Virus Infections
  • RSV MAT Lot 1 vaccine (GSK3888550A)
  • +4 more
  • West Palm Beach, Florida
  • +35 more
Jul 14, 2022

Influenza Vaccine Trial in United States (TIV, Trivalent Inactivated Influenza Virus Vaccine, FluMist, Influenza Virus Vaccine

Completed
Has Results
  • Influenza Vaccine
  • TIV, Trivalent Inactivated Influenza Virus Vaccine
  • FluMist, Influenza Virus Vaccine Live
  • Jonesboro, Arkansas
  • +18 more
Sep 10, 2021

Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)

Completed
Has Results
  • Influenza
  • Influenza Immunisation
  • Influenza Virus Quadrivalent Inactivated Vaccine
  • Rochester, New York
  • +1 more
Apr 29, 2021

Influenza, Influenza Immunisation Trial in Atlanta (Influenza Virus Vaccine Inactivated)

Completed
  • Influenza
  • Influenza Immunisation
  • Influenza Virus Vaccine Inactivated
  • Atlanta, Georgia
    Emory Clinic - Winship Cancer Institute
Aug 5, 2021

Influenza Trial in Bangkok (GPO Tri Fluvac vaccine, Licensed influenza vaccine)

Recruiting
  • Influenza
  • GPO Tri Fluvac vaccine
  • Licensed influenza vaccine
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Aug 23, 2022

Immunity, Cellular Trial in Saint Louis (Influenza Vaccine)

Active, not recruiting
  • Immunity, Cellular
  • Influenza Vaccine
  • Saint Louis, Missouri
    Washington University School of Medicine Infectious Disease Clin
Jan 5, 2021

Influenza, Human Trial in United States (FLU-Q-PAN H7N9 Formulation 1, FLU-Q-PAN H7N9 Formulation 2, FLU-Q-PAN H7N9 Formulation

Active, not recruiting
  • Influenza, Human
  • FLU-Q-PAN H7N9 Formulation 1
  • +5 more
  • Stockbridge, Georgia
  • +6 more
Apr 18, 2022

Influenza, Seasonal Influenza Trial in Vienna (Inactivated influenza vaccine (split virus, Vero cell-derived))

Completed
  • Influenza
  • Seasonal Influenza
  • Inactivated influenza vaccine (split virus, Vero cell-derived)
  • Vienna, Austria
    University Clinic for Clinical Pharmacology, General Hospital Vi
Oct 19, 2020

Influenza Trial in Raleigh, Rocky Mount, Statesville (NanoFlu, Fluzone HD - Day 0, Fluzone HD - Day 21)

Completed
Has Results
  • Influenza
  • NanoFlu
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 29, 2022

Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Fluzone HD)

Not yet recruiting
  • Respiratory Syncytial Virus
  • Placebo
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Sep 23, 2023

Influenza, Human Trial in United States (MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV),

Completed
Has Results
  • Influenza, Human
  • MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)
  • +2 more
  • Mobile, Alabama
  • +19 more
Jul 20, 2020

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Influenza Trial in Shangqiu (0.5ml Quadrivalent influenza vaccine, 0.25ml Quadrivalent influenza vaccine, 0.25ml Trivalent

Unknown status
  • Influenza
  • 0.5ml Quadrivalent influenza vaccine
  • +3 more
  • Shangqiu, Henan, China
    Henan Provincial Center for Disease Control and Prevention
Apr 22, 2020

Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)

Not yet recruiting
  • Influenza, Human
  • aQIV
  • QIV
  • Batumi, Georgia
  • +16 more
Oct 11, 2023